<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Quarterly report pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934.
Date of Report: December 13, 2000
Commission file number 000-23266
UroMed Corporation
(Exact name of registrant as specified in its charter)
Massachusetts 04 - 3104185
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
1400 Providence Highway
Norwood, MA 02062
(Address of principal
executive offices)
(781) 762-2080
(Registrant's telephone number, including area code)
<PAGE>
Item 5. Other Events
On December 13, 2000, The Company issued the statement contained within this
filing.
Item 7. Exhibits
Exhibit Number Description
-------------- ------------
99.1 Statement issued December 13, 2000 regarding
misstatements in a recent individual investor
magazine article
<PAGE>
SIGNATURES
Pursuant to requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
UroMed Corporation
Date: December 13, 2000 /s/ Daniel Muscatello
-------------- ----------------------------------
Daniel Muscatello, President and
Chief Executive Officer
Date: December 13, 2000 /s/ Domenic C. Micale
-------------- -----------------------------------
Domenic C. Micale, Vice President
of Finance and Administration, and
Treasurer
